On Tuesday shares of OvaScience, Inc. (NASDAQ:OVAS) closed at $24.47. On April 30, OvaScience, Inc. (NASDAQ:OVAS), announced the appointment of John E. Sexton, Ph.D., President of New York University (NYU), to the OvaScience Board of Directors.
Energy Focus, Inc. (NASDAQ:EFOI) in last trading activity moved up 12.16% to close at $6.27. Company weekly performance is 17.86% while its quarterly performance stands at 39.33%. Energy Focus, Inc. (NASDAQ:EFOI) is -41.46% away from its 52 week high. Energy Focus, Inc. (NASDAQ:EFOI), announced financial results for its first quarter ended March 31, 2015. Net sales of $13.1 million increased 167% from the prior year’s first quarter and 39% sequentially from the fourth quarter; Gross margin of 41.1% represents a gain of 12.2 percentage points over the prior year’s first quarter and a 7.1 percentage point improvement from the fourth quarter of 2014.
On last trading day Fibria Celulose SA (NYSE:FBR) decreased -1.65% to close at $13.75. Its volatility for the week is 2.07% while volatility for the month is 2.49%. FBR’s sales growth for past 5 years was 21.70% and its EPS growth for past 5 years was -41.00%. Fibria Celulose SA (NYSE:FBR) monthly performance is -1.93%.
Lantronix, Inc. (NASDAQ:LTRX) has 1.20% insider ownership while its institutional ownership stands at 25.60%. In last trading activity company’s stock closed at $1.63. On April 29, Lantronix, Inc. (NASDAQ: LTRX), reported results for its fiscal 2015 third quarter ended March 31, 2015. Net revenue was $10.4 million for the third quarter of fiscal 2015, a decrease of $1.1 million, compared with $11.6 million for the third quarter of fiscal 2014 and a decrease of $291,000 compared with $10.7 million for the second quarter of fiscal 2015.
On last trading day Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) decreased -7.83% to close at $2.12. Its volatility for the week is 6.77% while volatility for the month is 5.80%. SNSS’s sales growth for past 5 years was 8.40% and its EPS growth for past 5 years was 42.80%. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) monthly performance is -11.67%. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) reported financial results for the first quarter ended March 31, 2015. Loss from operations for the three months ended March 31, 2015 was $8.8 million. As of March 31, 2015, cash, cash equivalents and marketable securities totaled $39.8 million.